Interestingly, prostate-specific membrane antigen (PSMA) expression has been confirmed in the neovasculature of GB and the diagnostic role of radiolabelled PSMA PET/CT or PET/MRI in patients with gliomas and GBs has recently been reviewed 78-81. The gene discussed is FOLH1; the disease is Guillain-Barre syndrome.